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INTRODUCTION 
The term “opioid” refers to illegal substances like heroin 
and illicit fentanyl and other synthetic drugs as well as 
legal prescription medications used to treat moderate to 
severe pain. 
 
Since 2007, the number of Ohioans dying due to 
unintentional drug overdose has been on the rise.1 
• Number one cause of injury-related death 
 
A number of initiatives are underway that aim to reduce 
the number of intentional drug overdoses and combat 
inappropriate prescribing.1 
• OARRS 
• Prescribing Guidelines 
• Project DAWN 
 
Since 2012, the number of opioid prescriptions dispensed 
to patients has gone down, as can be seen in Figure 1. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Abuse of prescription opioids is a risk factor for use of 
heroin and fentanyl. 2 (CDC) 
 
Work continues to be done to ensure patients get the 
medications they need while limiting the number of 
prescription medications available for misuse and abuse. 
 
Pharmacists positive impact in medication therapy 
management programs is well documented. 
METHODS 
The Opioid Patient Education Program (OPEP) was developed for pharmacist use when dispensing opioid pain medications 
 
OPEP includes: 
• written materials to be provided to the patient 
• a checklist of points to be covered by the pharmacist in consultation with the patient 
• telephone follow-up call 14 days after the medication is dispensed 
 
The purpose of OPEP is to educate patients on safe use, storage, and disposal of opioid medications. 
OPEP was piloted in Kroger Pharmacies in five cities in Southeast Ohio from March 2017 – September 2017. 
 
Evaluation project data was collected in 2 ways: 
• Written surveys completed before and after the project 
• Surveys took approximately 30 minutes to complete 
• Pre-survey mailed to participating pharmacists and collected  
• Post-survey collected from participating pharmacists during focus group discussions 
• Focus group discussions conducted after the conclusion of the pilot program 
• Conducted with participating pharmacists for one hour at their store locations 
 
RESULTS 
 
Pharmacists in the eight OPEP pilot sites interacted with  
1,030 patients receiving opioid pain medications as of 
September 26, 2017.  
 
The majority of pharmacists were satisfied with OPEP 
overall, as well as the various components of the program.  
 
The majority of pharmacists also perceived that patients 
were satisfied with the counseling and materials received 
through OPEP. 
 
Overall, pharmacists agreed that OPEP contributed to 
positive medication use habits among patients and makes 
a difference in medication misuse. 
FUTURE DIRECTIONS 
Results from this project will determine whether OPEP is 
rolled out on a larger scale to additional pharmacies. 
Focus group discussions will be used to inform how to 
improve and modify the program for future use. 
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AIM 
To assess a model for enhancing the involvement of 
community pharmacists in helping patients use opioid pain 
medications safely. 
Figure 1: Number of Non-Liquid Opioid Doses Dispensed to 
Ohio Patients 2011-2016 
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Figure 3: Selected Post-Survey Results 
